BONESUPPORT Gains 510(k) for Cerament in Interbody Fusion

BONESUPPORT’s 510(k) submission for Cerament bone void filler to include an indication for spinal interbody fusion received FDA clearance to market. As previously stated, U.S. market introduction for the application is slated by end of 2025.

Cerament is an injectable, moldable and drillable synthetic bone void filler comprising 40%...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us